10% market penetration for aortic stenosis. This therefore doesn't factor in much market penetration, and obviously doesn't consider the broader heart failure market which is likely to follow with FDA Clearance:
Ann: Major Milestone Achieved with FDA Clearance for EchoSolv AS, page-51
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.005(2.22%) |
Mkt cap ! $141.9M | |||
| Open | High | Low | Value | Volume |
| 22.0¢ | 22.5¢ | 22.0¢ | $395.1K | 1.796M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 518757 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 122492 | 4 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |